CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.

Also called NCT05066789

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05066789
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT05066789. Randomized; no masking; primary purpose treatment. Start 2022-01-17 (actual); primary completion 2024-03-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
Acronym
SMART-CHOICE4
Intervention (Device)
Type of stent
Intervention (Drug)
Duration of DAPT
Lead sponsor
Samsung Medical Center (class: other)

Record details

Record id
cardio:ct-nct05066789
Content hash
273e337451d1e85cfa242bca8f1acd4345344e76fa7e3b1ba564c280d83a9c4b